Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Canadian Hot Stock Club - CHSC -- Ignore unavailable to you. Want to Upgrade?

To: ToySoldier who wrote (615)	6/17/1998 10:11:00 AM
From: John Fairchild	Respond to of 1307

HPC is back in play. HYAL & SHIRE ANNOUNCE PHASE III RESULTS OF HYCLINDA(TM) MISSISSAUGA, Ont., June 17 /CNW/ - Hyal Pharmaceutical Corporation (NASDAQ/NNM:HYALF; TSE:HPC) and their development partner, Shire Pharmaceuticals Group plc, announced today the results of Shire's Phase III clinical study on the first of its HyAcne development projects: HyClinda(TM). HyClinda is an improved formulation of clindamycin (an established antibiotic agent widely used for the topical treatment of acne), utilizing Hyal Pharmaceutical Corporation's Hyaluronan Induced Targeting (HIT(TM)) Technology. HIT is a drug delivery technology based on hyaluronic acid, which is designed to maintain efficacy whilst improving tolerability and patient acceptability. HyClinda, in two strengths, was compared with Dalacin T(R) (clindamycin lotion 1%, Pharmacia and Upjohn) and a placebo formulation of HIT without the active clindamycin. A total of 375 subjects were included in the study, which was a double blind, parallel group study of 12 weeks duration. All three active treatments were statistically significantly more effective than placebo at 12 weeks (p less than 0.001), at reducing the numbers of inflamed and non-inflamed lesions. There were no statistically significant differences in efficacy between the three active treatments. The three HIT based formulations were well tolerated, and showed improvements in cosmetic acceptability producing less evidence of stinging and skin greasiness. HyClinda has been developed for outlicense to a specialist dermatology company for worldwide marketing. Discussions are already underway with a number of interested parties. Commenting today, Rolf Stahel, Chief Executive of Shire said: ''We are pleased with these results which demonstrate proof-of-principle of the HIT delivery system.'' Dr. Zenas B. Noon, Jr., Chief Executive of Hyal, concurred with Mr. Stahel and added that ''together with Solarase(TM), Hyal's product for the treatment of actinic keratosis, the results with HyClinda further validate the utility of the HIT delivery system.''" Hyal Pharmaceutical Corporation is a drug delivery development company engaged in research and development utilizing its proprietary Hyaluronan Induced Targeting (HIT(TM)) Technology and Hyaluronan Improved Liposome Technology (HILT(TM)). The Company's strategy is to commercialize its developments by outlicensing on a global basis. This news release may contain forward-looking statements relating to the future performance of Hyal. Forward-looking statements, specifically those concerning future performance, are subject to certain risks and uncertainties, and actual results may differ materially. These risks and uncertainties are detailed from time to time in the Company's filings with the appropriate securities commissions. %SEDAR: 00003081E -30-

To: ToySoldier who wrote (615)	6/17/1998 10:23:00 AM
From: The Osprey	Read Replies (2) \| Respond to of 1307

Toy, I posted this to MMR but since this is Canadian Hot Stocks Club and MMR is in the model portfolio I thought it best to post here as well so everyone can keep an eye on it.I am not hyping,just reporting what I found and encouraging anyone who is interested to do their own DUE DILIGENCE To: ToySoldier (717 ) From: Osprey Wednesday, Jun 17 1998 10:16AM ET Reply # of 720 Toy, I spoke with Mr.Battrum at 6:30 yesterday morning.Now Mr. Battrum knows who Osprey is as a result of this posting and that is fine with me. Here are the highlights as discussed. (1)Mr. Battrum advised that the deal with Ridgewood was finalized. (2)A Mr.Cai was mentioned as a person who was forming a company in Hong Kong with Mr. Battrum to funnel the money out of the project for control purposes and ease of transfer. Apparently it is easier to move money from Hong Kong than it is from China.(Makes sense to me.) (3)Apparently Mr Cai has to apply for a passport and visa to Hong Kong and this takes 10 days and the time is up on Monday coming. (4)I was concerned re the drop in world oil prices and Mr. Battrum said the refinery in China close to the Ansai Field is paying 19.70/Barrel us for gasoline and I got the idea from Mr. Battrum this was a price that was fixed regardless of world prices.(Perhaps someone can check this out or shed some light here)Apparently there is a market for all that can be produced.Mr. Battrum was not concerned about this. (5)Mr. Battrum also stated that the climate there is not unlike that of Calgary or Edmonton and when I asked if it was monsoonal he said no and no problems for work program to begin when ready. (6)When I asked about the PP investors having an escape clause if the price goes below the PP price he said they did not and they have a 120 day hold period from the date of the PP which I forgot to get. (7)Mr. Barry Whelan is the P.Geo with MMR and he is the same P.geo with ANV.Mr. Whelan advised they have more comprehensive info to work with on the Ansai field now that they have visited and done more work and we should be pleased with the news when it is reported but he would not elaborate for obvious reasons.(This man is doing everything by the book and is careful not to disclose any insider info and I respect this) (8)When I asked when a news release would be forthcoming he said soon but gave no timeframe.(Once again by the book) (9)The funding is needed to finalize the deal with Ridgewood and the work program although Mr. Battrum said the work program can be done a bit at a time so the whole 4,050,000US in the budget is not needed up front as I underrstand it. (10) When I asked if the next PP would be brokered or non-brokered Mr. Battrum was non-committal and said he hasn't decided yet.(IMHO it will be non-brokered but time will tell) I must point out that Mr. Battrum was very professional and co-operative and I presume is working with the best interests of shareholders at heart and he wants this deal to go through with no problems and I re-iterated the need for some news to keep the shareholders informed. I would suggest anyone who would like to call Mr. Battrum to do so and ask any questions I may have missed that should have been asked. As a synopsis I do not see the price going below .18/share and some good news is coming so IMHO these are firesale prices.Remember that financing has to be done soon and to prevent dilution I would suspect the price to go up to a higher level.Look for a NR possibly next week and prices to move up slowly and controlled.(This is my opinion only) Osprey

To: ToySoldier who wrote (615)	6/17/1998 11:44:00 AM
From: The Osprey	Read Replies (1) \| Respond to of 1307

Toy, Keep an eye on HPC.Its moving a bit.Up .07 or 10% right now. Osprey

To: ToySoldier who wrote (615)	6/18/1998 1:14:00 AM
From: Editor1	Read Replies (2) \| Respond to of 1307

That is right Toy, Tourmaline is a semi-precious gem used in jewelry. It is highly sought after in the orient. There are several different qualities and colours. the best quality tourmaline in the world comes from the region where Cachet Enterprises is mining. The Kalunga Wbeba area in the Lundazi district, Eastern Province of Zambia. The mining will be alluvial in nature. There is up to 2 meters of overburden on the sight before they hit the gem gravel. Of all tourmaline's by far the most expensive is the watermelon tourmaline. It actually looks just like a slice of watermelon ! This watermelon tourmaline is found in abundance at their Zambian concessions.